Arlette Emième

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

Raoul Moh, Delphine Gabillard, Calixte Guéhi et al. · The Lancet Global Health · 2017 · 171 citations · Full text

Medicine, Health Sciences, Pharmacotherapy +12

Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication

Gérard-Menan Kouamé, Anders Boyd, Raoul Moh et al. · Clinical Infectious Diseases · 2017 · 60 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Virological response and resistances over 12 months among HIV‐infected children less than two years receiving first‐line lopinavir/ritonavir‐based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort

Clarisse Amani‐Bosse, Désiré Lucien Dahourou, Karen Malateste et al. · Journal of the International AIDS Society · 2017 · 18 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters

Albert Minga, Charlotte Lewden, Delphine Gabillard et al. · AIDS · 2011 · 14 citations

Public Health, Biostatistics, Infectious Diseases +15

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

Jean Baptiste N’Takpé, Delphine Gabillard, Raoul Moh et al. · EBioMedicine · 2020 · 13 citations · Full text

Public Health, Immunology, Infectious Diseases +17